SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-19-000183
Filing Date
2019-02-19
Accepted
2019-02-19 21:45:14
Documents
1
Period of Report
2019-02-14

Document Format Files

Seq Description Document Type Size
1 form4-02192019_090201.html 4  
1 form4-02192019_090201.xml 4 27788
  Complete submission text file 0001415889-19-000183.txt   29236
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O JDJ FAMILY OFFICE SERVICES P.O. BOX 962049 BOSTON MA 02196
Business Address
Ross Edmund Burke Jr. (Reporting) CIK: 0001682557 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 19616971